SUN PHARMA ADVANCED RESEARCH COMPANY
Back to All Ratios
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| CEPS(Rs) | 48.17 | -10.17 | -11.55 | -6.50 |
What is the latest Cash Earnings per Share (CEPS) ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2026 | 48.17 |
| Mar2025 | -10.17 |
| Mar2024 | -11.55 |
| Mar2023 | -6.50 |
How is Cash Earnings per Share (CEPS) of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2026 | 48.17 | Positive | |
| Mar2025 | -10.17 | Negative | |
| Mar2024 | -11.55 | Negative | |
| Mar2023 | -6.5 | - | |
Other Financial Ratios of SUN PHARMA ADVANCED RESEARCH COMPANY
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,421.9 Cr | 6.7% | 0.6% | 36.5% | Stock Analytics | |
| PRIME FOCUS | ₹27,841.2 Cr | 11.4% | 20.4% | 84.5% | Stock Analytics | |
| SAGILITY | ₹21,304.7 Cr | 1.3% | 5% | 2.7% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹15,246.6 Cr | -0.6% | -7.2% | -41.4% | Stock Analytics | |
| INDEGENE | ₹14,280.9 Cr | 3.4% | 4.3% | 4% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹14,138.1 Cr | 4% | -3.9% | -13.4% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 6.7% |
0.6% |
36.5% |
| SENSEX | 0.7% |
-3.9% |
-8.9% |
You may also like the below Video Courses